Akso Health Group (AHG) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
2.45$'dan işlem gören Akso Health Group (AHG), 233M değerindeki bir Financial Services şirketidir. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 67/100 puan alıyor.
Son analiz: 15 Mar 2026Akso Health Group (AHG) Finansal Hizmetler Profili
Akso Health Group operates a social e-commerce platform in China, focusing on the Xiaobai Maimai App for diverse consumer products. The company distinguishes itself by offering consultancy and IT support services alongside its e-commerce operations, positioning it within the competitive Chinese financial services sector.
Yatırım Tezi
Akso Health Group presents a high-risk, high-reward investment profile. The company's negative profit margin of -1190.8% and gross margin of -3.3% raise concerns about its financial sustainability. With a market capitalization of $0.24 billion and a negative P/E ratio of -6.17, valuation is speculative. Growth catalysts include expanding its product offerings and leveraging its social e-commerce platform. However, investors should carefully consider the risks associated with its financial performance and competitive landscape. The company's beta of -0.66 suggests a lower volatility compared to the market.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $0.24 billion reflects its current valuation in the financial market as of March 15, 2026.
- Negative P/E ratio of -6.17 indicates the company is currently not profitable.
- Profit margin of -1190.8% highlights significant challenges in achieving profitability.
- Gross margin of -3.3% suggests difficulties in managing the cost of goods sold.
- Beta of -0.66 indicates a lower volatility compared to the market.
Rakipler & Benzerleri
Güçlü Yönler
- Established social e-commerce platform.
- Diverse product offerings.
- Provision of consultancy and IT support services.
- Subsidiary of Webao Limited.
Zayıflıklar
- Negative profit margin.
- Low gross margin.
- Limited brand recognition compared to larger e-commerce platforms.
- Small number of employees.
Katalizörler
- Upcoming: Expansion of product categories on the Xiaobai Maimai App to attract new customers and increase sales.
- Ongoing: Enhanced user engagement through personalized recommendations and loyalty programs to improve customer retention.
- Upcoming: Strategic partnerships with established brands and suppliers to enhance product offerings and supply chain efficiency.
- Ongoing: Geographic expansion within China to tap into underserved markets and increase its customer base.
- Ongoing: Investment in advanced technologies such as AI and machine learning to improve operational efficiency and customer experience.
Riskler
- Ongoing: Intense competition in the Chinese e-commerce market from established players and emerging platforms.
- Potential: Changing consumer preferences and the need to adapt to evolving trends in online shopping.
- Potential: Regulatory changes in China that could impact the company's operations and financial performance.
- Potential: Economic slowdown in China that could reduce consumer spending and impact sales.
- Ongoing: Negative profit margin and low gross margin, raising concerns about financial sustainability.
Büyüme Fırsatları
- Expansion of Product Categories: Akso Health Group can drive growth by expanding its product categories on the Xiaobai Maimai App. Focusing on high-margin products and catering to niche markets can improve profitability. The e-commerce market in China is projected to reach trillions of dollars by 2028, offering a substantial opportunity for growth. Timeline: Ongoing.
- Enhanced User Engagement: Improving user engagement through personalized recommendations, loyalty programs, and interactive social features can increase customer retention and drive sales. Leveraging data analytics to understand user behavior and preferences is crucial. The social commerce market is expected to grow significantly, providing a favorable environment. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic partnerships with established brands and suppliers can enhance product offerings and improve supply chain efficiency. Collaborating with key influencers and content creators can also boost brand awareness and drive traffic to the platform. This can lead to increased sales and market share. Timeline: Within the next 12-18 months.
- Geographic Expansion: Expanding its operations to new regions within China can tap into underserved markets and increase its customer base. Adapting its product offerings and marketing strategies to local preferences is essential for success. The Chinese e-commerce market is vast and diverse, offering ample opportunities for geographic expansion. Timeline: Within the next 24-36 months.
- Leveraging Technology: Investing in advanced technologies such as artificial intelligence and machine learning can improve operational efficiency, personalize customer experiences, and enhance fraud detection. Implementing blockchain technology can also improve supply chain transparency and build trust with customers. Timeline: Ongoing.
Fırsatlar
- Expansion of product categories.
- Enhanced user engagement.
- Strategic partnerships.
- Geographic expansion within China.
Tehditler
- Intense competition in the Chinese e-commerce market.
- Changing consumer preferences.
- Regulatory changes.
- Economic slowdown in China.
Rekabet Avantajları
- Established social e-commerce platform in China.
- Diverse product offerings on the Xiaobai Maimai App.
- Provision of consultancy and IT support services.
- Subsidiary of Webao Limited, providing financial backing and resources.
AHG Hakkında
Akso Health Group, formerly known as Xiaobai Maimai Inc., was founded in 2014 and rebranded in December 2021. Headquartered in Beijing, China, the company operates a social e-commerce mobile platform, primarily through its Xiaobai Maimai App. This platform offers a wide array of products, including food and beverage items, wine, cosmetics, fashion and apparel, entertainment products, housewares, and home appliances. In addition to its e-commerce activities, Akso Health Group provides consultancy and information technology support services. The company also engages in trading branded products and promoting various goods. As of July 13, 2021, Akso Health Group functions as a subsidiary of Webao Limited. The company aims to leverage social commerce trends in the Chinese market to connect consumers with a diverse product range and supplementary services.
Ne Yaparlar
- Operates a social e-commerce mobile platform in China.
- Offers a variety of products through the Xiaobai Maimai App, including food, beverages, cosmetics, and apparel.
- Provides consultancy and IT support services.
- Trades in branded products.
- Promotes products through its platform.
- Functions as a subsidiary of Webao Limited.
İş Modeli
- Generates revenue through the sale of products on its Xiaobai Maimai App.
- Earns fees from consultancy and IT support services.
- Profits from trading branded products.
- Revenue from advertising and promotion services on its platform.
Sektör Bağlamı
Akso Health Group operates within the competitive Chinese financial services sector, specifically in the realm of social e-commerce. This market is characterized by rapid growth, driven by increasing internet penetration and consumer adoption of online shopping. The company faces competition from established e-commerce giants and emerging fintech platforms. Success in this environment requires effective marketing, strong customer engagement, and the ability to adapt to evolving consumer preferences and regulatory changes.
Kilit Müşteriler
- Consumers in China who use mobile devices for online shopping.
- Businesses seeking consultancy and IT support services.
- Brands looking to promote their products on the Xiaobai Maimai App.
- Users of social e-commerce platforms.
Finansallar
Grafik & Bilgi
Akso Health Group (AHG) hisse senedi fiyatı: $2.45 (-0.05, -2.00%)
Son Haberler
-
Alto Neuroscience, Immunovant And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga · 2 Nis 2026
-
Pure Energy Announces Completion of an Earn-In Transaction in Esmeralda County
Yahoo! Finance: AHG News · 17 Mar 2026
-
Akso Health Group (NASDAQ:AHG) Shares Gap Up – Still a Buy?
defenseworld.net · 15 Mar 2026
-
Nio, Zevra Therapeutics, Vertex Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
benzinga · 10 Mar 2026
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
AHG için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
AHG için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, AHG'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Rakipler & Benzerleri
Son Haberler
Alto Neuroscience, Immunovant And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Pure Energy Announces Completion of an Earn-In Transaction in Esmeralda County
Akso Health Group (NASDAQ:AHG) Shares Gap Up – Still a Buy?
Nio, Zevra Therapeutics, Vertex Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Yönetim: Yilin Wang
CEO
Yilin Wang serves as the CEO of Akso Health Group, leading a team of 9 employees. Information regarding Yilin Wang's detailed career history, educational background, and previous roles is not available in the provided data. However, as CEO, Yilin Wang is responsible for the overall strategic direction and operational management of the company.
Sicil: Due to limited information, specific achievements and milestones under Yilin Wang's leadership cannot be detailed. However, the CEO's role is crucial in navigating the competitive Chinese e-commerce market and driving the company's growth strategy.
Akso Health Group ADR Bilgileri Sponsorlu
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company that trades on U.S. stock exchanges. AHG, as an ADR, allows U.S. investors to invest in Akso Health Group, a Chinese company, without the complexities of cross-border transactions. The ADR is denominated in U.S. dollars and trades during U.S. market hours.
- Ana Piyasa Sembolü: Primary stock exchange is in China, with headquarters in Qingdao.
- ADR Seviyesi: 2
- ADR Oranı: 1:1
AHG Hakkında Sıkça Sorulan Sorular
AHG için değerlendirilmesi gereken temel faktörler nelerdir?
Akso Health Group (AHG) şu anda yapay zeka skoru 67/100, orta puanı gösteriyor. Temel güçlü yan: Established social e-commerce platform.. İzlenmesi gereken birincil risk: Ongoing: Intense competition in the Chinese e-commerce market from established players and emerging platforms.. Bu bir finansal tavsiye değildir.
AHG MoonshotScore'u nedir?
AHG şu anda MoonshotScore'da 67/100 (Derece B) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
AHG verileri ne sıklıkla güncellenir?
AHG fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler AHG hakkında ne diyor?
AHG için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
AHG'a yatırım yapmanın riskleri nelerdir?
AHG için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition in the Chinese e-commerce market from established players and emerging platforms.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
AHG'ın P/E oranı nedir?
AHG için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için AHG'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
AHG aşırı değerli mi, yoksa düşük değerli mi?
Akso Health Group (AHG)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
AHG'ın temettü verimi nedir?
Akso Health Group (AHG) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Information is based on available data as of March 15, 2026.
- Financial data may be subject to change.
- Analyst opinions may vary.